Bristol-Myers Squibb stock fluctuates, with Wells Fargo raising price target to $52.00 and Bank of America downgrading from "buy" to "neutral" at $60.
Bristol-Myers Squibb (NYSE:BMY) stock fell 0.1% on Tuesday, trading at $48.47 per share after hitting a low of $48.24. Analyst reports have been mixed, with Wells Fargo & Co. raising its price target to $52.00 and maintaining an "equal weight" rating, while Bank of America downgraded the stock from "buy" to "neutral" with a $60.00 target price. Other analysts have also issued reports with varying ratings and price targets.
April 18, 2024
4 Articles